14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.05 $4.30 Thursday, 2nd May 2024 GERN stock ended at $3.95. This is 3.19% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 9.38% from a day low at $3.84 to a day high of $4.20.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
May 04, 2023 $2.68 $2.75 $2.64 $2.70 4 496 022
May 03, 2023 $2.53 $2.70 $2.50 $2.67 5 250 914
May 02, 2023 $2.52 $2.56 $2.46 $2.48 4 702 774
May 01, 2023 $2.46 $2.57 $2.45 $2.56 3 892 328
Apr 28, 2023 $2.38 $2.48 $2.35 $2.46 3 404 059
Apr 27, 2023 $2.43 $2.43 $2.33 $2.38 3 405 132
Apr 26, 2023 $2.39 $2.45 $2.36 $2.43 3 785 568
Apr 25, 2023 $2.65 $2.66 $2.39 $2.42 4 225 073
Apr 24, 2023 $2.69 $2.71 $2.51 $2.65 7 549 302
Apr 21, 2023 $2.58 $2.69 $2.46 $2.67 6 519 890
Apr 20, 2023 $2.45 $2.61 $2.35 $2.51 13 743 682
Apr 19, 2023 $2.06 $2.52 $2.06 $2.49 19 986 406
Apr 18, 2023 $2.08 $2.10 $2.04 $2.08 2 419 208
Apr 17, 2023 $1.97 $2.06 $1.97 $2.05 5 120 536
Apr 14, 2023 $2.04 $2.04 $1.95 $1.97 3 416 267
Apr 13, 2023 $2.00 $2.08 $1.97 $2.04 5 941 496
Apr 12, 2023 $2.01 $2.04 $1.96 $1.97 4 200 924
Apr 11, 2023 $2.02 $2.06 $1.99 $2.01 5 325 350
Apr 10, 2023 $2.03 $2.08 $1.99 $2.02 3 260 154
Apr 06, 2023 $2.00 $2.09 $1.97 $2.05 5 283 655
Apr 05, 2023 $2.07 $2.08 $1.96 $2.00 6 075 294
Apr 04, 2023 $2.16 $2.17 $1.99 $2.07 8 694 731
Apr 03, 2023 $2.14 $2.21 $2.12 $2.17 4 811 370
Mar 31, 2023 $2.18 $2.21 $2.13 $2.17 4 722 166
Mar 30, 2023 $2.25 $2.26 $2.12 $2.14 4 112 694
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT